Iovance Biotherapeutics Reaches Analyst Target Price

In recent trading, shares of Iovance Biotherapeutics Inc (Symbol: IOVA) have crossed above the average analyst 12-month target price of $50.20, changing hands for $52.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg

In recent trading, shares of Iovance Biotherapeutics Inc (Symbol: IOVA) have crossed above the average analyst 12-month target price of $50.20, changing hands for $52.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg